Illumina, Inc. (ILMN)
Pre-market:
| Previous close | 106.48 |
| Open | 106.88 |
| Bid | 105.01 x 200 |
| Ask | 105.10 x 200 |
| Day's range | 103.50 - 106.98 |
| 52-week range | 89.00 - 213.12 |
| Volume | |
| Avg. volume | 1,599,634 |
| Market cap | 16.731B |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.04 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 150.34 |
PR NewswireIllumina releases 2023 Corporate Social Responsibility Report
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report. The report highlights the company's ongoing commitments and progress made in 2023 toward advancing human health by serving as a champion for patients, communities, employees, and the planet.
Simply Wall St.One Illumina Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in Illumina, Inc.'s ( NASDAQ:ILMN ) during the past 12 months. That is...
PR NewswireAnna Richo joins Illumina's Board of Directors
Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice President, Strategic Advisor to the General Counsel and CEO at Cargill, Inc. a global food production and agricultural company.
